Jacobio (01167) Announces Monthly Return for February 2026

Bulletin Express
03/02

Jacobio Pharmaceuticals Group Co., Ltd. (stock code: 01167) disclosed its monthly return report for the period ended 28 February 2026. The total authorized share capital remained at USD 100,000, representing 1.00 billion ordinary shares with a par value of USD 0.0001 each.

At the end of the month, the total number of issued shares (excluding treasury shares) stood at 786.67 million, with 5.08 million treasury shares held, resulting in 791.76 million shares issued in total. According to the filing, the company confirmed that it has satisfied the applicable public float requirement, specified at 25%. No changes were recorded in share options, warrants, convertibles, or other share issuance arrangements during this period.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10